ctrl K

Stoke Therapeutics Inc. (STOK)

NASDAQ: STOK · Real-Time Price · USD

9.88

0.12 (1.23%)

At close: May 01, 2025, 3:59 PM

9.45

-4.30%

Pre-market: May 02, 2025, 04:13 AM EDT

Stoke Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Revenue	36.55M	8.78M	12.4M	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	4.44M	n/a	3.54M	2.23M	1.93M	450K	214K	113K
Gross Profit	32.11M	8.78M	8.87M	-2.23M	-1.93M	-450K	-214K	-113K
Operating Income	-101.37M	-114.77M	-104.36M	-86.06M	-53.04M	-35.68M	-12.78M	-5.55M
Interest Income	n/a	n/a	3.12M	120K	744K	3.35M	270K	n/a
Pretax Income	-88.98M	-104.7M	-101.07M	-85.81M	-52.24M	-32.33M	-12.52M	-5.56M
Net Income	-88.98M	-104.7M	-93.11M	-84.71M	-50.61M	-28.52M	-12.52M	-5.56M
Selling & General & Admin	48.79M	41.32M	38.92M	31.9M	20.85M	11.91M	4.41M	1.96M
Research & Development	89.13M	82.23M	77.84M	54.17M	32.2M	23.76M	8.37M	3.6M
Other Expenses	n/a	n/a	167K	140K	57K	2K	-10K	-4K
Operating Expenses	137.93M	123.55M	116.76M	86.06M	53.04M	35.68M	12.78M	5.55M
Interest Expense	n/a	n/a	3.12M	120K	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	137.93M	123.55M	116.76M	86.06M	53.04M	35.68M	12.78M	5.55M
Income Tax Expense	n/a	n/a	-7.96M	-1.09M	-1.63M	-3.8M	260K	n/a
Shares Outstanding (Basic)	54.01M	43.99M	38.9M	36.74M	33.49M	17.97M	23.51M	12.79M
Shares Outstanding (Diluted)	54.01M	43.99M	38.9M	36.74M	33.49M	17.97M	23.51M	12.79M
EPS (Basic)	-1.65	-2.38	-2.39	-2.31	-1.51	-1.59	-0.53	-0.43
EPS (Diluted)	-1.65	-2.38	-2.39	-2.31	-1.51	-1.59	-0.53	-0.43
EBITDA	-101.37M	-112.3M	-102.81M	-83.58M	-50.32M	-35.23M	-12.57M	-5.44M
EBIT	-101.37M	-114.77M	-104.36M	-85.81M	-52.24M	-35.68M	-12.78M	-5.55M
Depreciation & Amortization	n/a	2.47M	3.54M	2.23M	1.93M	450K	214K	113K